<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03282201</url>
  </required_header>
  <id_info>
    <org_study_id>TransfusionArthroplasty</org_study_id>
    <nct_id>NCT03282201</nct_id>
  </id_info>
  <brief_title>A Survey on Blood Transfusions in Major Artrhoplasty Operations</brief_title>
  <official_title>The Effect of Blood Transfusion on Recovery After Major Arthroplasties</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diskapi Teaching and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Diskapi Teaching and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The rate of hip, knee arthroplasties and their revision are increasing every year. The
      incidence of blood transfusion in these operations are reported 18%, 68%, and 39%, 67%,
      respectively. Blood transfusion is known to increase the risk of pulmonary, septic, wound and
      thromboembolic complications and is related to mortality. Restrictive transfusion protocols
      has cost-effective results in terms of reducing these complications, promoting early
      discharge and reduced frequency of re-admission.

      Within this context, we aimed to evaluate the transfusion practice in our hospital, define
      the transfusion indicators and compare the transfused and non transfused patients in terms of
      recovery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After obtaining ethical approval Patients undergoing hip or knee arthroplasty or revision
      arthroplasty will be included in this prospective observational study.

      Patient characteristics (age , gender, body mass index, ASA physical status, anticoagulant
      medication) Preoperative: hemoglobin, hematocrit, platelet, INR, APTT, PT values, the
      precence of preoperative anemia, anemia treatment modalities will be recorded.

      Intraopreative: type and duration of surgery, anesthesia method, monitoring methods used, the
      amount of intraoprative adminestred fluids (crystalloid-colloid), amount of hemorrhage
      Postoperative: hemoglobin-hematocrit-platelet leve The amount of blood transfusion and the
      product used (erythrocyte suspension, fresh frozen plasma, thrombocyte-fibrinogen-factor
      concentration-cryoprecipitate-other ) Hemoglobin-hematocrit-platelet level before and after
      transfusion Indications for transfusion; hemoglobin threshold / physiological transfusion
      indicator; tachycardia, hypotension, low flow rate, desaturation, low SvO2, inotropic
      requirement, etc. / comorbidities / monitorisation findings, other, Discharge time of
      patients Early upright position (postoperative 2nd day), information on walking capacities
      (TUG - The Time Up and Go test) will be recorded and compared between transfused and
      non-transfused patients
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 15, 2017</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Discharge time</measure>
    <time_frame>Postoperative day 1-6 days</time_frame>
    <description>Discharge time from hospital</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TUG test</measure>
    <time_frame>Postoperative day 1-2</time_frame>
    <description>Walking without help</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Arthropathy of Hip</condition>
  <condition>Arthropathy of Knee</condition>
  <arm_group>
    <arm_group_label>Transfused</arm_group_label>
    <description>Patients in whom blood transfusion is used</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nontransfused</arm_group_label>
    <description>Patients in whom blood transfusion is not used</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Transfusion</intervention_name>
    <description>Transfusion of red blood cells, fresh frozen plasma, platelets</description>
    <arm_group_label>Transfused</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing major atrhroplasty
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing major atrhroplasty

        Exclusion Criteria:

          -  Pediatric patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dilek Yazicioglu, Assoc Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Netherlands: Ministry of Health, Welfare and Sports</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dilek Yazicioglu, Assoc Prof</last_name>
    <phone>+905336957855</phone>
    <email>dilek.yazicioglu@hotmail.com</email>
  </overall_contact>
  <reference>
    <citation>Poitras S, Wood KS, Savard J, Dervin GF, Beaule PE. Predicting early clinical function after hip or knee arthroplasty. Bone Joint Res. 2015 Sep;4(9):145-51. doi: 10.1302/2046-3758.49.2000417.</citation>
    <PMID>26336897</PMID>
  </reference>
  <reference>
    <citation>Cram P, Vaughan-Sarrazin MS, Wolf B, Katz JN, Rosenthal GE. A comparison of total hip and knee replacement in specialty and general hospitals. J Bone Joint Surg Am. 2007 Aug;89(8):1675-84.</citation>
    <PMID>17671004</PMID>
  </reference>
  <results_reference>
    <citation>Engoren M, Mitchell E, Perring P, Sferra J. The effect of erythrocyte blood transfusions on survival after surgery for hip fracture. J Trauma. 2008 Dec;65(6):1411-5. doi: 10.1097/TA.0b013e318157d9f9.</citation>
    <PMID>19077635</PMID>
  </results_reference>
  <results_reference>
    <citation>Kotz√© A, Carter LA, Scally AJ. Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. Br J Anaesth. 2012 Jun;108(6):943-52. doi: 10.1093/bja/aes135.</citation>
    <PMID>22593128</PMID>
  </results_reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2017</study_first_submitted>
  <study_first_submitted_qc>September 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 13, 2017</study_first_posted>
  <last_update_submitted>September 13, 2017</last_update_submitted>
  <last_update_submitted_qc>September 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Diskapi Teaching and Research Hospital</investigator_affiliation>
    <investigator_full_name>DILEK YAZICIOGLU</investigator_full_name>
    <investigator_title>Associate Proffesor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

